Please login to the form below
Origin
This page shows the latest Origin news and features for those working in and with pharma, biotech and healthcare.
Menlo slumps as itching drug fails mid-stage trial
company. The 10-week trial compared treatment with serlopitant versus placebo in 233 patients with self-reported chronic pruritus of unknown origin (CPUO), who experienced persistent itching for at least six
Latest news
-
Origin opens new facility in Alderley Park
addition to our ever-expanding global network of clients,” said Rich Quelch, global head of marketing, Origin. ... This announcement coincides with the addition of Graham Howieson as a new board member of Origin.
-
Grail’s multi-cancer blood test gets FDA breakthrough status
Could detect multiple cancers from single blood sample
-
The Communiqué Awards: what are judges looking for?
Entering awards that demand evidence and rigour is therefore a great way of building up your agency’s capabilities in presenting objectives, insights and the origins of your creative ideas.
-
GSK and Sanofi join Finland's 500,000 genomics study
They say the genomic data can be analysed faster and more effectively than in populations of more heterogenous origins, which they say should significantly improving the chances of breakthrough findings.
-
Gradually, then suddenly
Think of any example of failure and you can usually trace its origins back many years before its sudden collapse.
More from news
Approximately 1 fully matching, plus 104 partially matching documents found.
Latest Intelligence
-
Every superhero has an origin story – what’s yours?
Every good origin story outlines the trials and tribulations that our hero faces on his path to success. ... Utilising your origin story. Publishing phase 1 data unlocks your drug’s origin story, adding a crucial layer of detail that informs how
-
Bombarded with information – the challenge of crowded digital channels
Brands are missing out on a crucial part of the story: the origin story.
-
A snapshot of… Enterprise Therapeutics
In this month’s issue of PME, we take a look at Enterprise Therapeutics and talk to CEO Dr John Ford about the company’s technologies and the obstacles it faces in the biotech sector. Enterprise Therapeutics is discovering and developing new
-
New truths and realities in these strange times
It can be a daunting new world. PoTS and COVID-19. The Origins Insights team is working with the charity PoTS UK on a qualitative research project investigating the impact of ... Debbie Waterman, a Research Director at Origins Insights, observed recently:
-
Emerging use cases of blockchain in healthcare and the life sciences
Drug development and supply chain management. Two key concepts in drug manufacturing and supply chain management are provenance (the origin and/or ownership of an entity such as a drug, which
More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.
Latest appointments
-
Bedrock Group bolsters team with three key appointments
Rounding out the new hires is Vicky O’Connor (pictured below, right), who joins Origins Insights – a Bedrock Group company – as strategic solutions director. ... As Origins Insights grows, our expert team of qualitative researchers and strategists
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
October 2020: diversity and inclusion in clinical trials round-up
Disparities in sickle cell disease. Globally, sickle cell disease is among the most common genetic disorders and predominantly affects individuals from African, Mediterranean, Arabian, and Indian origins.
-
The Unknown Unknowns
At Origins Insights, we are committed to listening to patients to understand their experiences. ... Drop us a line at contact@origins-insights.com and let's arrange time to speak.
-
Do you know what PoTS is?
Dr Morwenna Opie-Moran, Trustee of PoTS UK and Clinical Psychologist affiliated with the London Cardiovascular Clinic, commented that “Working with Origins has been such an eye-opener. ... For more information, please visit the PoTS UK website or
-
Leadership change within Bedrock Group
Consisting of two separate companies; Origins Insights and Bedrock Healthcare Communications, Bedrock Group has grown from a small UK based start-up consultancy in 2011, to an award-winning leading player
-
Origins Insights: views from the team
First in a video series from the Origins Insights team discussing some of our views, experiences, values and opinions across many aspects of qualitative patient research activities. ... Over the coming weeks, the Origins Insights team will be sharing a
More from PMHub
Approximately 18 fully matching, plus 22 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Sinovac’s COVID-19 vaccine appears safe in older adults
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer introduces new logo in a ‘shift from commerce to science’
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
